Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2025 Earnings Call Transcript May 8, 2025
Iovance Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.36 EPS, expectations were $-0.25.
Operator: Good day and thank you for standing by. Welcome everyone to the Iovance Biotherapeutics First Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session....
